GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AdaptHealth Corp (NAS:AHCO) » Definitions » GF Value

AHCO (AdaptHealth) GF Value : $10.95 (As of Jul. 18, 2025)


View and export this data going back to 2018. Start your Free Trial

What is AdaptHealth GF Value?

As of today (2025-07-18), AdaptHealth's share price is $9.22. AdaptHealth's GF Value is $10.95. Therefore, AdaptHealth's Price-to-GF-Value for today is 0.84. Based on the relationship between the current stock price and the GF Value, GuruFocus believes AdaptHealth is Modestly Undervalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

  1. We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
  2. We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
  3. Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.


AdaptHealth  (NAS:AHCO) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations All-in-One Screener Examples (1)
Possible Value Trap, Think TwicePredictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.


Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.


AdaptHealth's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=9.22/10.95
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AdaptHealth GF Value Related Terms

Thank you for viewing the detailed overview of AdaptHealth's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


AdaptHealth Business Description

Traded in Other Exchanges
N/A
Address
220 West Germantown Pike, Suite 250, Plymouth Meeting, PA, USA, 19462
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Executives
Jason A Clemens officer: Chief Financial Officer 220 WEST GERMANTOWN PIKE, SUITE 250, C/O ADAPTHEALTH LLC, PLYMOUTH MEETING PA 19462
Dale B Wolf director
Shaw Rietkerk officer: Chief Revenue Officer C/O ADAPTHEALTH LLC, 220 WEST GERMANTOWN PIKE, SUITE 250, PLYMOUTH MEETING PA 19462
Williams David Solomon Iii director 6272 CONDON AVE, LOS ANGELES CA 90056
James E Flynn director, 10 percent owner, other: Director by Deputization 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Albert A. Prast officer: Chief Technology Officer 3325 BARTLETT BLVD., ORLANDO FL 32811
Skyknight Aero Holdings, Llc director C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Christine E. Archbold officer: Chief Accounting Officer FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Everest Hill Group Inc. 10 percent owner TROPIC ISLE BUILDING, P O BOX 3331, ROAD TOWN TORTOLA D8 VG 1110
Daniel Bunting officer: COO - Branch Operations 12200 N.W. AMBASSADOR DRIVE, SUITE 326, KANSAS CITY MO 64163
Christopher J Joyce officer: General Counsel C/O ALLIANCE ENTERTAINMENT CORP, 110 EAST 59TH STREET 18TH FLOOR, NEW YORK NY 10022
Skyknight Aero Holdings Ii, Llc director C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Skyknight Capital, L.p. director C/O SKYKNIGHT CAPITAL, ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Skyknight Capital Fund Ii, L.p. director ONE LETTERMAN DRIVE, BUILDING C, SUITE 3-950, SAN FRANCISCO CA 94129
Stephen P Griggs director, officer: Co-Chief Executive Officer 1360 PLACE VENDOME, WINTER PARK FL 32789